SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2026-09-21 17:10
Tx date 2026-09-17 		$---
Grace Therapeutics, Inc. 		Kottayil, George
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+12,200 vol 		54,700
Filed 2026-09-21 17:08
Tx date 2026-09-17 		$---
Grace Therapeutics, Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+12,200 vol 		69,217
Filed 2026-09-21 17:06
Tx date 2026-09-17 		$---
Grace Therapeutics, Inc. 		Davis, Alfred Brian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+12,200 vol 		54,700
Filed 2026-09-21 17:04
Tx date 2026-09-17 		$---
Grace Therapeutics, Inc. 		Neugeboren, Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+12,200 vol 		54,700
Older filings
Filed 2026-09-18 12:16
Tx date 2026-09-18 		$---
Brookfield Property Partners L.P. 		Brookfield Property Partners L.P.
1 - Issuer
Direct Ownership
Units 5.750% Class A Preferred Units, Series 3
38 - Redemption, retraction, cancellation, repurchase
-400,000 vol 		0
Filed 2026-09-18 12:15
Tx date 2026-09-17 		$---
Brookfield Property Partners L.P. 		Brookfield Property Partners L.P.
1 - Issuer
Direct Ownership
Units 5.750% Class A Preferred Units, Series 3
38 - Redemption, retraction, cancellation, repurchase 		$5,500,000
+400,000 vol
$13.75 each 		400,000
Filed 2026-09-18 12:14
Tx date 2014-12-12 		$---
Brookfield Property Partners L.P. 		Brookfield Property Partners L.P.
1 - Issuer
Direct Ownership
Units 5.750% Class A Preferred Units, Series 3
00 - Opening Balance-Initial SEDI Report
Filed 2026-09-17 14:22
Tx date 2026-09-17 		$---
Brookfield Property Partners L.P. 		Brookfield Property Partners L.P.
1 - Issuer
Direct Ownership
Units 6.375% Preferred Units, Series 2
38 - Redemption, retraction, cancellation, repurchase
-400,000 vol 		0
Filed 2026-09-17 14:22
Tx date 2026-09-16 		$---
Brookfield Property Partners L.P. 		Brookfield Property Partners L.P.
1 - Issuer
Direct Ownership
Units 6.375% Preferred Units, Series 2
38 - Redemption, retraction, cancellation, repurchase 		$6,100,000
+400,000 vol
$15.25 each 		400,000
Filed 2026-09-17 14:20
Tx date 2014-12-12 		$---
Brookfield Property Partners L.P. 		Brookfield Property Partners L.P.
1 - Issuer
Direct Ownership
Units 6.375% Preferred Units, Series 2
00 - Opening Balance-Initial SEDI Report
Filed 2026-09-10 16:12
Tx date 2026-09-09 		$---
Grace Therapeutics, Inc. 		Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$214,000
+100,000 vol
$2.14 each 		121,357
Filed 2026-09-10 16:11
Tx date 2026-09-09 		$---
Grace Therapeutics, Inc. 		Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$241,000
+100,000 vol
$2.41 each
Filed 2026-09-10 14:58
Tx date 2026-09-09 		$---
Grace Therapeutics, Inc. 		Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$241,000
+100,000 vol
$2.41 each 		121,357
Filed 2026-09-10 14:58
Tx date 2026-09-09 		$---
Grace Therapeutics, Inc. 		Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$241,000
+100,000 vol
$2.41 each
Filed 2026-09-01 16:57
Tx date 2026-08-28 		$---
Grace Therapeutics, Inc. 		Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+267,160 vol 		946,184
Filed 2026-09-01 16:55
Tx date 2026-08-28 		$---
Grace Therapeutics, Inc. 		Kumar, Amresh
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+35,760 vol 		127,500
Filed 2026-09-01 16:54
Tx date 2026-08-28 		$---
Grace Therapeutics, Inc. 		Macdonald, Robert Loch
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+54,690 vol 		180,070
Filed 2026-09-01 16:51
Tx date 2026-08-28 		$---
Grace Therapeutics, Inc. 		DelAversano, Robert John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+33,660 vol 		100,290
Filed 2026-09-01 16:50
Tx date 2026-08-28 		$---
Grace Therapeutics, Inc. 		DelAversano, Robert John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+33,660 vol
Filed 2026-09-01 16:50
Tx date 2026-08-28 		$---
Grace Therapeutics, Inc. 		DelAversano, Robert John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+33,660 vol